KYMR · Kymera Therapeutics, Inc. Common Stock

KYMR Kymera Therapeutics, Inc. Common Stock

Healthcare & Biotech · Healthcare · ← Healthcare & Biotech Index

Gesamt +123%RS-Rating 70vom Hoch -28%Ø $-Vol 41MMax-Runup +973%Max-DD -90%ADR 4.1%Score 111Setups 5Rallyes 7Earnings 25Surf 100%🏄 10/20-Surfer

▲ im Chart anklicken → springt zur Zeile

Grade	Base-Start	Breakout	Tage	Tiefe%	Vorlauf%	Δ Tag%	Gap%	Vol×	Dry-Up%	ADR%	ext10%	Surf%	Setup	Formation	Katalysator
B	2022-07-08	2022-08-03	18	23.1	+101	+17.3	16.7	1.9	27	8.3	18	40	Episodic Pivot (Gap)	High Tight Flag	News: Will Humanigen Inc. (HGEN) Report Negative Q2 Earnings? What You Should Know ↗
B	2022-11-11	2022-12-14	22	24.3	+75	+14.6	31.6	12.9	12	6.8	6	40	Episodic Pivot (Gap)	—	SEC 8-K: Reg FD disclosure ↗
C	2024-05-14	2024-07-09	37	26.2	+21	+23.4	11.6	4.9	5	5.2	26	22	Episodic Pivot (Gap)	—	SEC 8-K: Reg FD disclosure ↗
B	2025-05-02	2025-06-02	20	22.0	+85	+45.5	35.0	9.7	10	7.3	39	40	Episodic Pivot (Gap)	VCP (Contraction)	SEC 8-K: Reg FD disclosure ↗
B	2025-11-24	2025-12-08	9	7.4	+73	+41.5	33.9	10.7	14	5.5	36	100	Episodic Pivot (Gap)	Flag / Pennant	SEC 8-K: Material agreement

Breakouts 5Trefferquote 60%Ø gehalten +5.2%Median +6.8%Ø Peak +30%Ø hergegeben −25%

Breakout	G	Entry	gehalten	Peak	hergeg.	Tage	Exit
2022-08-03	B	26.45	+6.8%	+33.0%	−26.2%	18	2022-08-29
2022-12-14	B	32.94	-15.3%	+3.9%	−19.2%	1	2022-12-15
2024-07-09	C	39.63	-0.5%	+22.9%	−23.3%	19	2024-08-05
2025-06-02	B	35.98	+21.3%	+39.7%	−18.4%	19	2025-06-30
2025-12-08	B	68.80	+13.5%	+49.7%	−36.2%	15	2025-12-30

Regel: Einstieg am Breakout-Pivot, Trailing-Stop = Tagesschluss unter dem 20-EMA. gehalten = realisierter Gewinn bis zum Stop · Peak = max. Run-Up (MFE) · hergeg. = Peak − gehalten · „offen" = Position läuft noch.

Jahr	Rendite	Spanne	Max-DD	Setups	Schluss
2020	+86%	261%	-29%		62.00
2021	+2%	194%	-64%		63.49
2022	-61%	398%	-78%	2	24.96
2023	+2%	315%	-72%		25.46
2024	+58%	138%	-31%	1	40.23
2025	+93%	430%	-53%	2	77.81
2026	-5%	45%	-25%		74.13

▲ 2025-04-08 → 2025-12-08 +348% (168 HT)

Auslöser: SEC 8-K: Reg FD disclosure

2025-06-02 +46% [SEC 8-K] Reg FD disclosure
2025-12-08 +42% [SEC 8-K] Material agreement

▲ 2023-10-27 → 2024-02-27 +297% (82 HT)

Auslöser: Earnings: Earnings-Report (SEC 8-K 2.02)

2023-11-02 +5% [Earnings] Earnings-Report (SEC 8-K 2.02)
2023-11-14 +16% [News] Kymera Therapeutics Announces Publication of Phase 1 Trial Results for

▲ 2020-09-09 → 2020-12-28 +237% (76 HT)

Auslöser: — (Momentum/sektorgetrieben)

▲ 2022-06-01 → 2022-08-24 +143% (58 HT)

Auslöser: News: Will Humanigen Inc. (HGEN) Report Negative Q2 Earnings? What You Should Know

2022-08-03 +17% [News] Will Humanigen Inc. (HGEN) Report Negative Q2 Earnings? What You Shoul

▲ 2021-04-13 → 2021-09-10 +114% (105 HT)

Auslöser: — (Momentum/sektorgetrieben)

▲ 2022-10-10 → 2023-02-02 +98% (79 HT)

Auslöser: News: Where Kymera Therapeutics Stands With Analysts

2022-11-10 +10% [News] Where Kymera Therapeutics Stands With Analysts
2022-12-14 +15% [SEC 8-K] Reg FD disclosure

▲ 2024-06-28 → 2024-09-24 +76% (60 HT)

Auslöser: SEC 8-K: Reg FD disclosure

2024-07-09 +23% [SEC 8-K] Reg FD disclosure